EyePoint Pharmaceuticals Inc
EYPT
Get informed when a big investor buys or sells
+ FollowMarket Cap$285.06M
Close$
$-1.94
164.3% downside
Current Fair Value
164.3% downsideOvervalued by 164.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $285.06 Million |
|---|---|
| Enterprise Value | $196.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.17 |
| Beta | 1.68 |
| Outstanding Shares | 86,543,000 |
Return
| Return on Equity | -184.27% |
|---|---|
| Return on Assets | -134.38% |
| Return on Invested Capital | -168.63% |
Valuation & Multiples
| P/E Ratio | -0.91 |
|---|---|
| PEG | -1.54 |
| Price to Sales | - |
| Price to Book Ratio | 3.01 |
| Enterprise Value to Revenue | 70.62 |
| Enterprise Value to EBIT | -0.63 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-1.01
Average shareholder expectationRevenue Estimate
$443,000
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.91
Average shareholder expectationRevenue Estimate
$231,154
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 189.69% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 108.00% |
|---|---|
| Total Invested | $13,750▼ 100.00% |
| Investors Holding | 5▼ 204.00% |
ESG Score
No data